Normalising comparative effectiveness trials as clinical practice.

Clinical care Comparative effectiveness Embed High-quality evidence Pragmatic Trials

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
15 Sep 2021
Historique:
received: 13 05 2021
accepted: 24 08 2021
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 18 9 2021
Statut: epublish

Résumé

There is a lack of high-quality evidence underpinning many contemporary clinical practice guidelines embedded in the healthcare systems, leading to treatment uncertainty and practice variation in most medical disciplines. Comparative effectiveness trials (CETs) represent a diverse range of research that focuses on optimising health outcomes by comparing currently approved interventions to generate high-quality evidence to inform decision makers. Yet, despite their ability to produce real-world evidence that addresses the key priorities of patients and health systems, many implementation challenges exist within the healthcare environment.This manuscript aims to highlight common barriers to conducting CETs and describes potential solutions to normalise their conduct as part of a learning healthcare system.

Identifiants

pubmed: 34526083
doi: 10.1186/s13063-021-05566-1
pii: 10.1186/s13063-021-05566-1
pmc: PMC8442385
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

620

Informations de copyright

© 2021. The Author(s).

Références

N Engl J Med. 2012 May 3;366(18):1659-61
pubmed: 22551126
Eur Heart J. 2019 Apr 14;40(15):1236-1240
pubmed: 29688309
EGEMS (Wash DC). 2015 Mar 10;3(1):1122
pubmed: 25992388
N Engl J Med. 2016 Dec 15;375(24):2395-2400
pubmed: 27974039
EGEMS (Wash DC). 2016 Aug 10;4(3):1233
pubmed: 27683668
Med J Aust. 2021 Feb;214(2):62-65.e1
pubmed: 33429459
Learn Health Syst. 2017 Nov 02;2(1):e10044
pubmed: 31245573
JAMA. 2020 May 19;323(19):1895-1896
pubmed: 32227198

Auteurs

Tom Briffa (T)

University of Western Australia, Perth, Western Australia, Australia.

Tanya Symons (T)

University of Sydney, Sydney, New South Wales, Australia.

Nikolajs Zeps (N)

Epworth HealthCare, Richmond, Victoria, Australia.

Nicola Straiton (N)

University of Sydney, Sydney, New South Wales, Australia. nicola.straiton@clinicaltrialsalliance.org.au.
Australian Clinical Trials Alliance, Suite 1, Level 2, 24 Albert Road, Melbourne, VIC, 3205, Australia. nicola.straiton@clinicaltrialsalliance.org.au.

William Odita Tarnow-Mordi (WO)

University of Sydney, Sydney, New South Wales, Australia.

John Simes (J)

University of Sydney, Sydney, New South Wales, Australia.

Ian A Harris (IA)

Ingham Institute, Liverpool, New South Wales, Australia.

Melinda Cruz (M)

University of Sydney, Sydney, New South Wales, Australia.
University of New South Wales, Sydney, New South Wales, Australia.

Steven A Webb (SA)

Monash University, Melbourne, Victoria, Australia.

Edward Litton (E)

Fiona Stanley Hospital, Murdoch, Western Australia, Australia.

Alistair Nichol (A)

Monash University, Melbourne, Victoria, Australia.

Christopher M Williams (CM)

University of Newcastle, Callaghan, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH